Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Patil

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
Breast Cancer Research and Treatment|June 10, 2021
A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imagingAki Morikawa, Milan Grkovski, Sujata Patil, et al.
Journal of Cancer Survivorship : Research and Practice|October 27, 2020
Use of patient-reported controls for secular trends to study disparities in cancer-related job lossVictoria S Blinder, Carolyn E Eberle, Christina Tran, et al.
Breast Cancer Research and Treatment|October 8, 2017
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impactDavid B Page, Hannah Wen, Edi Brogi, et al.
The Oncologist|January 4, 2019
Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5-Year Follow-upRui Wang, Lillian M Smyth, Neil Iyengar, et al.
Breast Cancer Research and Treatment|August 29, 2019
Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testingW Iris Zhi, Patricia Chen, Alice Kwon, et al.
Clinical Breast Cancer|February 6, 2010
Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan resultsPatrick G Morris, Catherine Van Poznak, Shanu Modi, et al.
European Radiology|January 14, 2018
Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosisJoao V Horvat, Manuela Durando, Soledad Milans, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2013
Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchymaLouisa Bokacheva, Jennifer B Kaplan, Dilip D Giri, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 6, 2019
Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After ChemoradiationOliver S Chow, Sujata Patil, Metin Keskin, et al.
Cancer Medicine|January 10, 2014
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancerGary A Ulaner, Anne Eaton, Patrick G Morris, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|June 10, 2021
A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imagingAki Morikawa, Milan Grkovski, Sujata Patil, et al.
Journal of Cancer Survivorship : Research and Practice|October 27, 2020
Use of patient-reported controls for secular trends to study disparities in cancer-related job lossVictoria S Blinder, Carolyn E Eberle, Christina Tran, et al.
Breast Cancer Research and Treatment|October 8, 2017
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impactDavid B Page, Hannah Wen, Edi Brogi, et al.
The Oncologist|January 4, 2019
Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5-Year Follow-upRui Wang, Lillian M Smyth, Neil Iyengar, et al.
Breast Cancer Research and Treatment|August 29, 2019
Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testingW Iris Zhi, Patricia Chen, Alice Kwon, et al.
Clinical Breast Cancer|February 6, 2010
Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan resultsPatrick G Morris, Catherine Van Poznak, Shanu Modi, et al.
European Radiology|January 14, 2018
Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosisJoao V Horvat, Manuela Durando, Soledad Milans, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2013
Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchymaLouisa Bokacheva, Jennifer B Kaplan, Dilip D Giri, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 6, 2019
Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After ChemoradiationOliver S Chow, Sujata Patil, Metin Keskin, et al.
Cancer Medicine|January 10, 2014
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancerGary A Ulaner, Anne Eaton, Patrick G Morris, et al.
Pageof 23